EVERREST Developing a Therapy for Fetal Growth Restriction

CompletedOBSERVATIONAL
Enrollment

142

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

February 28, 2022

Study Completion Date

February 28, 2022

Conditions
Fetal Growth Retardation
Trial Locations (4)

Unknown

University Medical Center Hamburg-Eppendorf, Hamburg

Maternal-Fetal Unit Hospital Clinic de Barcelona, Barcelona

Lund University Hospital and University Hospital Malmö, Malmo

University College London Hospital, London

All Listed Sponsors
collaborator

University College London Hospitals

OTHER

collaborator

Universitätsklinikum Hamburg-Eppendorf

OTHER

collaborator

Hospital Clinic of Barcelona

OTHER

collaborator

Lund University

OTHER

lead

University College, London

OTHER

NCT02097667 - EVERREST Developing a Therapy for Fetal Growth Restriction | Biotech Hunter | Biotech Hunter